Mitapivat: Side Effects, Uses & Monitoring
Facts extracted from current FDA product labeling for Mitapivat. Educational only — not medical advice.
Labeled uses
PYRUKYND is indicated for the treatment of hemolytic anemia in adults with pyruvate kinase (PK) deficiency.
Source: FDA labeling via NIH DailyMed (set 4ccee896…). Not affiliated with FDA or NIH.
Medical disclaimer: Always consult a qualified healthcare professional about any medication.